A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 110
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : 9HPT
Long Form : 9-Hole Peg Test
No. Year Title Co-occurring Abbreviation
2022 Anti-CD20 immunotherapy in progressive multiple sclerosis: 2-year real-world follow-up of 108 patients. EDSS, SDMT, T25FW
2022 Cross-sectional and longitudinal correlations between the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) and other outcome measures in multiple sclerosis. AMSQ, EDSS, MS, PROM, T25FW
2022 Improvement in the multiple sclerosis functional composite score by multi-function swing suspension training program. MFSST, MS, MSFC, PASAT, T25FW
2022 Neurological Recovery with Interferon-gamma Treatment in Friedreich's Ataxia. FA, FARS, T25FW
2022 Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scales. Bain, EDSS, MS-QOL, PwMS, QSI, QUEST, SARA, tremor-QOL
2022 Quantitative physical performance tests can effectively detect Degenerative Cervical Myelopathy: A systematic review and meta-analysis. 30MWT, DCM, FTT, PPT, SST
2022 The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis. CIS, DMT, EDSS, MS, MxA, RRMS, T25FW
2021 Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis. EDSS, HC, MHI, MRI, MS, MWI, ProgMS, RRMS
10  2021 Effects of tactile stimulation on the sensory, motor and cognitive function in people with multiple sclerosis. BBT, HMR, MS, PASAT, RSS, SDMT
11  2021 Hand Function as Predictor of Motor Symptom Severity in Individuals with Parkinson's Disease. FOG, FOG-Q, HD, HY, nFOG, PD, UPDRS
12  2021 Implementation of evidence-based assessment of upper extremity in stroke rehabilitation: From evidence to clinical practice. BBT, FMA-UE, SAFE
13  2021 Italian translation and psychometric validation of the ABILHAND-26 and its correlation with upper limb objective and subjective measures in multiple sclerosis subjects. MAM-36, PROM, PwMS, UL
14  2021 Long-term outcomes and complications associated with operative and nonoperative treatment of distal radius fractures. Do we need to restore anatomy to have satisfactory clinical outcome? DASH, DRFs, PRWE
15  2021 Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis. EDSS, FSS, MRI, MSIS, SPMS, SPMS, T25FW
16  2021 The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis. EDSS, GNDS, PROMs, T25FW
17  2020 Acoustic Speech Analytics Are Predictive of Cerebellar Dysfunction in Multiple Sclerosis. MS
18  2020 Analyzing the functional effects of dynamic and static splints after radial nerve injury. ---
19  2020 Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities. alpha-KGD, cyt c, EDSS, NMO, PBMCs, SDMT, SIRT1
20  2020 Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance. 25FWT, CIS, EDSS
21  2020 Construct validity of the 9-Hole Peg Test and Purdue Pegboard Test in people with mild to moderately severe Parkinson's disease. MAM-36, PD, PPT
22  2020 Cortical and Deep Gray Matter Perfusion Associations With Physical and Cognitive Performance in Multiple Sclerosis Patients. CVD, DGM, DSC, GM, MS, MSSS, MTT, nCBF, SDMT, T25FW, WBV
23  2020 Diffusion tensor imaging of normal-appearing cervical spinal cords in patients with multiple sclerosis: Correlations with clinical evaluation and cerebral diffusion tensor imaging changes. Preliminary experience. ADC, DTI, EDSS, FA, MS, RRMS, T25FW
24  2020 Effects of Constraint-Induced Movement Therapy on upper limb activity according to a bi-dimensional kinematic analysis in progressive multiple sclerosis patients: a randomized single-blind pilot study. CIMT, HGS, MS
25  2020 Effects of modified-release fampridine on upper limb impairment in patients with Multiple Sclerosis. MS, TMS
26  2020 Functional improvement in hand strength and dexterity after surgical treatment of cervical spondylotic myelopathy: a prospective quantitative study. CSM, MCI, mJOA
27  2020 Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial. EDSS, T25FW
28  2020 Long-term worsening of different body functions in persons with progressive multiple sclerosis. MSSS, RMI
29  2020 Nine Hole Peg Test asymmetry in refining upper limb assessment in multiple sclerosis. EDSS, MS, UL
30  2020 Predictors of Health Utility in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis: Implications for Future Economic Models of Disease-Modifying Therapies. EDSS, MSOAC, PASAT, RRMS, SPMS, T25FW
31  2020 Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis. EDSS, RCT, SPMS, T25FW
32  2020 Sex differences in brain atrophy in multiple sclerosis. GM, MS, VBM
33  2020 Smartphone-based remote assessment of upper extremity function for multiple sclerosis using the Draw a Shape Test. DaS, HC, MAE, PwMS, RFR, SVR, UE
34  2020 Trehalose in Machado-Joseph Disease: Safety, Tolerability, and Efficacy. 8MW, MJD, NESSCA, SARA, WHOQOL-BREF
35  2020 [Robotic mechanotherapy in patients with multiple sclerosis with impaired walking function]. EDSS, MoCA, MS, MSFC, SDMT
36  2019 Effect of different doses of gadolinium contrast agent on clinical outcomes in MS. EDSS, GBCAs, MSFC, PASAT, SPMS, T25FW
37  2019 Efficacy of Virtual Reality Combined With Real Instrument Training for Patients With Stroke: A Randomized Controlled Trial. VR
38  2019 Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data. EDSS, LCLA, SDMT, SF-36 PCS, T25FW
39  2019 Longitudinal assessment of hand function in individuals with multiple sclerosis. EDSS, MS, PMS, RRMS
40  2019 Measuring Hand Dexterity in People With Parkinson's Disease: Reliability of Pegboard Tests. ICCs, PD, PPT
41  2019 Multiple Sclerosis Functional Composite. MSFC, PASAT-3
42  2019 Open-label pilot study of oral methylprednisolone for the treatment of patients with friedreich ataxia. 1MW, FARS, FRDA, T25FW
43  2019 Rate of force development and relaxation scaling factors are highly sensitive to detect upper extremity motor impairments in multiple sclerosis. iMS, LF
44  2019 Retrospective correlation analysis of plasma Immunoglobulin G and clinical performance in CIDP. 40-MWT, CIDP, cIKS, MRC, P-IgG, P-IgG
45  2019 The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis. EDSS, MS, MSFC, PASAT, SDMT, T25FW
46  2019 Upper limb motor evoked potentials as outcome measure in progressive multiple sclerosis. 10MWT, 6MWT, LE, PwPMS, UE
47  2018 Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. EDSS, OR, T25FW
48  2018 Enhanced action performance following TMS manipulation of associative plasticity in ventral premotor-motor pathway. ccPAS, TMS
49  2018 Fatty fish intake and cognitive function: FINS-KIDS, a randomized controlled trial in preschool children. CI, FINS-KIDS, n-3 LC-PUFAs, RCT
50  2018 Functional, cognitive and physical outcomes 3 years after minor lacunar or cortical ischaemic stroke. ACE-R, mRS, NART, TUG
51  2018 Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies. 6MWD, BBS, FSS, HRQoL, ICF, IPA, MAG, MCS, MRC, PCS, SF-36, SMS, VAS
52  2018 Identifying and Quantifying Neurological Disability via Smartphone. HV, MS
53  2018 MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study. CIS, HC, MS, NBV, RRMS, SDMT, T2C
54  2018 Progressive multiple sclerosis, cognitive function, and quality of life. MS, SDMT, SF-36, T25FW, TRAIL-B
55  2018 Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity. EDSS, MUCCA, NMOSD, SC, T25FWS
56  2018 The Bayesian risk estimate at onset (BREMSO) correlates with cognitive and physical disability in patients with early multiple sclerosis. BREMSO, BREMSO, CC, ICV, MSSS, RRMS, SDMT, SPMS, T25-FW
57  2017 Cerebellar lobule atrophy and disability in progressive MS. BVMT, CVLT, HC, MS, SDMT
58  2017 Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set. CDP, EDSS, PPMS, T25FW, UDP
59  2017 Comparisons in fluctuation of muscle strength and function in patients with immune-mediated neuropathy treated with intravenous versus subcutaneous immunoglobulin. 40-MWT, GS, MRC
60  2017 How does performance of the Friedreich Ataxia Functional Composite compare to rating scales? FAFC, FARS, FRDA, LCLA, T25FW
61  2017 Nine-hole Peg Test and Ten-meter Walk Test for Evaluating Functional Loss in Chinese Charcot-Marie-Tooth Disease. 10-MWT, BBS, CMT, ONLS
62  2017 Serious games for arm rehabilitation of persons with multiple sclerosis. A randomized controlled pilot study. BBT, EQ-VAS, MS
63  2017 Validation of an environmentally-friendly and affordable cardboard 9-hole peg test. MS, PwMS
64  2016 Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis. ChiPASAT, LCLA, MS, MSFC, PASAT, SDMT, T25FW
65  2016 Distribution-based estimates of minimum clinically important difference in cognition, arm function and lower body function after slow release-fampridine treatment of patients with multiple sclerosis. 5-STS, MCID, PwMS, SDMT, SSST, T25FW
66  2016 Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis. ADL, AHFT, ComPET, ICF, PwMS, T25FW
67  2016 Fractional anisotropy to quantify cervical spondylotic myelopathy severity. CSM, DBSI, DTI, FA
68  2016 New Insights from Clinical Assessment of Upper Extremities in Cervical Traumatic Spinal Cord Injury. ASIA, JTHFT, SCI
69  2016 The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis. EDSS, IMPACT, SPMS, T25FW
70  2015 Correlation of the VEMP score, ambulation and upper extremity function in clinically isolated syndrome. CIS, cVEMP, EDSS, MS, oVEMP, PASAT, T25FW, VEMP
71  2015 Dose-response relationships using brain-computer interface technology impact stroke rehabilitation. ARAT, BCIs, LI, SIS
72  2015 Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy. CMT, FT, IMRL, MV, SEGT, SPM
73  2014 Changes in cognition, arm function and lower body function after slow-release Fampridine treatment. SDMT, SR, SSST, T25FW
74  2014 Changes in functional connectivity correlate with behavioral gains in stroke patients after therapy using a brain-computer interface device. ADL, ARAT, BCI, FC, HF, SIS
75  2014 Coin rotation task: a valid test for manual dexterity in multiple sclerosis. CRT, EDSS, MAS, MS, SARA
76  2014 Composite end points to assess delay of disability progression by MS treatments. EDSS, MS, SDP, T25FWT
77  2014 Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial. FARS, FRDA, ICARS
78  2014 Detecting clinically-relevant changes in progressive multiple sclerosis. EDSS, GNDS, MS, T25FW
79  2014 Dexterity as measured with the 9-Hole Peg Test (9-HPT) across the age span. ---
80  2014 Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients. CMAP, CMT, CMT1A, SNAP, T10MW
81  2014 Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains. BFW, CSF, EDSS, MS, PASAT, SDMT, SNRS
82  2014 The squares test as a measure of hand function in multiple sclerosis. EDSS, MS, ST
83  2013 Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients. DTI, MS, MSFC, PASAT, T25FW, TBSS, VBM, WM
84  2013 Neuropsychological, balance, and mobility risk factors for falls in people with multiple sclerosis: a prospective cohort study. MS, PwMS
85  2013 Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease. 25FTW, CSTs, DTI, FA, PCs, RD
86  2013 The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trial. AI, EDSS
87  2012 Probing modifications of cortical excitability during stroke recovery with navigated transcranial magnetic stimulation. ARAT, ICF, nTMS, SICI
88  2012 Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS. EDSS, PRO, T25FW
89  2011 Assessing dexterity function: a comparison of two alternatives for the NIH Toolbox. BOT, NIH
90  2011 Clinical scales in progressive MS: predicting long-term disability. EDSS, GNDS, MS, PP, T25FW
91  2011 Five times sit-to-stand test performance in Parkinson's disease. FTSTS, Mini-BEST, PD
92  2011 The 9-hole PEG test of upper extremity function: average values, test-retest reliability, and factors contributing to performance in people with Parkinson disease. PD
93  2011 The Armeo Spring as training tool to improve upper limb functionality in multiple sclerosis: a pilot study. ARAT, MS
94  2010 GABAergic but not anti-cholinergic agents re-induce clinical deficits after stroke. ---
95  2010 Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components? MS, MSFC, PASAT, PP, T25FW
96  2009 Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a. EDSS, HRQoL, INFb, MS54QoL, MSFC, PASAT, RRMS, Timed 25-FWT
97  2009 The search for responsive clinical endpoints in primary progressive multiple sclerosis. EDSS, PPMS, T25FW
98  2008 SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia. SARA, SCA
99  2008 Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. MS, SEPs
100  2007 Ipsilateral motor dysfunction from unilateral stroke: implications for the functional neuroanatomy of hemiparesis. ---